The Recurrent Pericarditis Market was valued at USD 0.5 billion in 2024 and is projected to reach USD 1.2 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several key factors, including the rising prevalence of cardiovascular diseases, advancements in treatment methodologies, and increasing awareness regarding recurrent pericarditis among healthcare...